Thailand issues health warning on batch of popular Hong Thai herbal inhalers
Sign up now: Get ST's newsletters delivered to your inbox
Results from samples of the Hong Thai Herbal Inhaler, Formula 2, revealed that the product failed to meet quality standards.
ST PHOTOS: WANG HUI FEN
Follow topic:
BANGKOK - The Thai Food and Drug Administration (FDA) has issued an official announcement regarding the results of laboratory testing on herbal medicinal products.
Samples of the Hong Thai Herbal Inhaler, Formula 2, registration number G 309/62, produced by Hong Thai Panich, were collected for laboratory analysis by the Department of Medical Sciences.
The analytical results revealed that the product failed to meet quality standards
This constitutes a violation under the Notification of the Ministry of Public Health on Standards, Purity, and Other Critical Characteristics Affecting Product Quality.
Thai Herbal Hong Thai, the manufacturer of the herbal inhaler, later announced the recall of Lot 000332
The herbal product had been registered or notified in 2021, and in order to protect consumers, the FDA has deemed it necessary to make the inspection results public.
The FDA therefore advises the public to exercise caution when purchasing or using this herbal product. The agency is currently considering legal action against the responsible parties in accordance with the law. THE NATION/ ASIA NEWS NETWORK
